CareDx®

Creating life-changing solutions that enable transplant patients to thrive.

[CareDx® @CareDx]

A new article in @CardioBusiness, featuring insights from @JeffTeuteberg and @JKobulnik , explores how our HeartCare platform—combining AlloMap® and AlloSure® Heart—is changing the post-transplant care path for #hearttransplant recipients.

[Cardiovascular Business @CardioBusiness]

Fewer biopsies, happier patients: Why molecular blood testing is a game-changer for managing heart transplant recipients @CareDx #cardiology https://t.co/dpqsI2GUKy

[Jeff Teuteberg @JeffTeuteberg]

⏰@CareDx lunch 🫀xplant symposium @ISHLT , discussing GEP & cfDNA use and what the future holds! #ISHLT2026 @TheJHLT

Thanks to our panelists: Anne van Beuningen @EmoryUniversity, @NirUrielMD, @YasMoayedi, Snehal Patel @NorthwellHealth

[The ISHLT @ISHLT]

Thank you to @CareDx for their generous support! Partners like CareDx, Inc. make the #ISHLT2026 Annual Meeting possible. See CareDx, Inc. on-site in Toronto at booth 505.

[Jeff Teuteberg @JeffTeuteberg]

🎉Congratulations to Robert Woodward on his 25th anniversary @CareDx‼️
His leadership has helped guide the development and evolution of innovations across our history and he embodies our mission and dedication to patients.

[World Kidney Day @worldkidneyday]

Today, we mark #WorldKidneyDay! This year is extra special as we celebrate the 20th anniversary of this global movement 🎉

The 2026 campaign #OurKidneysOurPlanet continues to focus on the prevention and early detection of kidney disease, while bringing planetary health into the conversation.

🎂 Share your WKD anniversary wishes with us: https://t.co/Y03zqnNbzJ

@ISNkidneycare @@ifkf_wka

#WorldKidneyDay #OurKidneysOurPlanet #KidneyHealthForAll #WorldKidneyDay20Years

[CareDx® @CareDx]

Wrapping up a great few days at #ASTSWinter! Our interactive
symposium with Dr. Matthew Cooper and Dr. Zoe Stewart Lewis
featured real-world AlloSure® cases, discussions on incorporating
AlloSure® Plus into clinical decision-making, and new data from the
KOAR study. @ASTSChimera

[10x Genomics @10xGenomics]

We’re collaborating with @CareDx to establish ImmuneScape™, a multiomics research initiative using our Xenium and Chromium Flex platforms to study immune mechanisms in organ rejection and therapeutic response. Read the full details in today’s release: https://t.co/NdtW63sqCB

[CareDx® @CareDx]

At #ASH25, interim data from ACROBAT (prospective, multicenter) evaluated AlloHeme—NGS‑based blood surveillance post‑HCT for AML/MDS.
Serial monitoring with a multi‑analyte algorithm shows potential to enable timely intervention & more personalized care.
DM for the poster.

[Nir Uriel, MD MSc @NirUrielMD]

Our latest analysis from the SHORE registry now in @TheJHLT comprised of nearly 2000 pts with heart transplant

Read here about the risk of dual + GEP/dd-cfDNA

https://t.co/p1sXtXIPBw

@JeffTeuteberg @KiranKhush1 @CareDx

[The ISHLT @ISHLT]

Interested in researching non-invasive #biomarkers + the use of AI/machine learning in the care of lung transplant recipients? 🔎 Apply to this #ISHLTResearchGrant that aims to improve access and/or clinical outcomes in #LungTx. 🫁
⠀
✍️📅 Submit your application by 30 September. Get more information and apply at 🔗 https://t.co/G6Cm6YKsma

[Jeff Teuteberg @JeffTeuteberg]

🙏Thanks to all of the SHORE PI’s and teams and @CareDx for their support.
Reviewing cell free 🧬 & GEP data for practice-changing analysis in a new era managing 🫀 xplant pts with noninvasive testing.
@KiranKhush1 @AndrewAKaoMD @spinneymd @SmidtHeart @NirUrielMD

[CareDx® @CareDx]

Exciting news! Dr. Nir Uriel is presenting new data from the SHORE registry in an oral presentation at #ISHLT2025 showing dual-positive HeartCare results are prognostic of worse outcomes, even when the biopsy is normal. ​

​Learn more: https://t.co/TW2lUuiOeI​

​#HeartTransplant

[CareDx® @CareDx]

We're thrilled to share the latest HeartCare data from SHORE at #ISHLT2025 investigating the association of redundant biopsies with outcomes. Spoiler alert – there was none! ​

​Dr. Jeff Teuteberg will be sharing more during an oral presentation: ​

https://t.co/g4zVEs1cN9

[CareDx® @CareDx]

Exciting #ISHLT2025 update: Erik Henricksen, PharmD is presenting new outcomes data highlighting excellent 5-year rejection free survival with fewer biopsies using HeartCare Surveillance.​

​More details: https://t.co/UZHItdtoiq​

​#HeartTransplant

[CareDx® @CareDx]

We’re pleased to announce new insights on #hearttransplant surveillance at #ISHLT2025! Dr. Ersilia DeFilippis is sharing a SHORE abstract in an oral presentation showing HeartCare’s effectiveness in a large cohort of men and women.

Read: https://t.co/iSFaa1vOzD ​

#Cardiology

[CareDx® @CareDx]

We’re pleased to announce the presentation of new data from the ACROBAT study at the 2025 Tandem Meetings!

Read more about the key findings here: https://t.co/uQWB89O3Fk

#Tandem25 ​#StemCellTransplant #HematologyOncology

[CareDx® @CareDx]

CareDx Appoints Jing Huang Chief Data and AI Officer — read more: https://t.co/ZtNPtTo2Pa

[CareDx® @CareDx]

CareDx Appoints Keith Kennedy Chief Operating Officer and Jessica Meng Chief Commercial Officer—read more: https://t.co/rpP2gt3cA3

[CareDx® @CareDx]

CareDx proudly sponsored the 2024 Transplant Games in Birmingham, Ala., the largest gathering of organ transplant recipients, donors and entire transplant community. Learn about Scott, a heart tx recipient, in this story by @scottminshalltv with @cbs_42.
https://t.co/m2zDC1Orft

[CareDx® @CareDx]

CareDx is honored to support the 2024 Transplant Games to celebrate the incredible strength and resilience of transplant patients and the legacy of life-saving donors and their families. Join us in cheering on these amazing athletes!